 <h1>Xopenex HFA Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>levalbuterol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about levalbuterol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Xopenex HFA.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to levalbuterol: inhalation aerosol powder, inhalation solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, levalbuterol (the active ingredient contained in Xopenex HFA) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking levalbuterol:</p><p>
<i>More common</i>
</p><ul>
<li>Fast heartbeat</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chest pain or tightness</li>
<li>dizziness</li>
<li>feeling “faint”</li>
<li>lightheadedness</li>
<li>troubled breathing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Confusion</li>
<li>cough</li>
<li>difficult or labored breathing</li>
<li>difficulty swallowing</li>
<li>drowsiness</li>
<li>extra heartbeat</li>
<li>fainting</li>
<li>fast, pounding, slow, or irregular heartbeat or pulse</li>
<li>hives, welts, itching, or rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>nausea</li>
<li>noisy breathing</li>
<li>rapid, deep breathing</li>
<li>redness of the skin</li>
<li>restlessness</li>
<li>stomach cramps</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking levalbuterol:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Chest pain</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>impaired consciousness</li>
<li>irregular or fast heartbeat</li>
<li>lightheadedness</li>
<li>nausea</li>
<li>nervousness</li>
<li>seizures</li>
<li>sleeplessness</li>
<li>sweating</li>
<li>tremor</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of levalbuterol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Accidental injury (in children 4 to 11 years of age)</li>
<li>anxiety</li>
<li>body aches or pain</li>
<li>chills</li>
<li>congestion</li>
<li>cough</li>
<li>dryness or soreness of the throat</li>
<li>fever</li>
<li>general aches and pains</li>
<li>headache</li>
<li>hoarseness</li>
<li>increased cough</li>
<li>leg cramps</li>
<li>loss of appetite</li>
<li>migraines or other headaches</li>
<li>muscle tightness</li>
<li>nervousness</li>
<li>runny or stuffy nose</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal growth filled with fluid or semisolid material</li>
<li>blemishes on the skin</li>
<li>blood in the urine</li>
<li>bloody nose</li>
<li>burning, dry, or itching eyes</li>
<li>burning or stinging of the skin</li>
<li>cough producing mucus</li>
<li>cramps</li>
<li>diarrhea</li>
<li>difficulty having a bowel movement</li>
<li>discharge from the eye</li>
<li>dry mouth or throat</li>
<li>ear pain</li>
<li>excessive tearing</li>
<li>eye itch</li>
<li>heavy menstrual bleeding</li>
<li>muscle pain</li>
<li>night sweats</li>
<li>numbness or decreased sensitivity of the hand</li>
<li>pain</li>
<li>painful cold sores or blisters on the lips, nose, eyes, or genitals</li>
<li>pimples</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>stomach pain</li>
<li>tingling sensation in the arms or legs</li>
<li>vaginal yeast infection</li>
<li>weight loss</li>
</ul><p>
<!-- end inhalation aerosol powder, inhalation solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to levalbuterol: inhalation aerosol, inhalation solution</i></p><h3>General</h3><p>This drug has been associated with paradoxical bronchospasm, cardiovascular effects, immediate hypersensitivity reactions, and hypokalemia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>ECG abnormal, ECG change, hypotension, and syncope occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Hypertension, tachycardia</p>
<p><b>Frequency not reported</b>: ECG abnormal, ECG change, hypotension, syncope</p>
<p><b>Postmarketing reports</b>: Arrhythmias (including atrial fibrillation, supraventricular tachycardia, extrasystoles)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Myalgia occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Leg cramps</p>
<p><b>Frequency not reported</b>: Myalgia<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Metabolic acidosis occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Changes in plasma glucose and serum potassium; metabolic acidosis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Central nervous system stimulation and hyperesthesia of the hand occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dizziness, migraine, tremor, nervousness</p>
<p><b>Frequency not reported</b>: Central nervous system stimulation, hyperesthesia of the hand<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pain, flu syndrome, accidental injury, asthenia, fever</p>
<p><b>Frequency not reported</b>: Ear pain, herpes simplex, chills, cyst<sup>[Ref]</sup></p><p>Ear pain, herpes simplex, chills, and cyst occurred in less than 2%.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Diarrhea, dry mouth, dry throat, nausea, gastroenteritis, vomiting, and constipation occurred in less than 2%.</p><p><b>Common</b> (1% to 10%): Dyspepsia</p>
<p><b>Frequency not reported</b>: Diarrhea, dry mouth, dry throat, nausea, gastroenteritis, vomiting, constipation</p>
<p><b>Postmarketing reports</b>: Gastroesophageal reflux disease (GERD), nausea</p><h3>Respiratory</h3><p>Viral infection, epistaxis, lung disorder, asthma exacerbation, and wheezing occurred in less than 2%.</p><p><b>Common</b> (1% to 10%): Asthma, pharyngitis, rhinitis, bronchitis, sinusitis, turbinate edema, cough increased, viral infection</p>
<p><b>Frequency not reported</b>: Epistaxis, lung disorder, asthma exacerbation, wheezing</p>
<p><b>Postmarketing reports</b>: Chest pain, dysphonia, dyspnea</p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Acne, sweating</p>
<p><b>Postmarketing reports</b>: Rash, urticaria</p><p>Acne and sweating occurred less than 2%.</p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic reactions</p>
<p><b>Postmarketing reports</b>: Angioedema, anaphylaxis</p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria, dysmenorrhea, vaginal moniliasis</p><p>Hematuria, dysmenorrhea, vaginal moniliasis occurred in less than 2%.</p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Lymphadenopathy</p><p>Lymphadenopathy occurred in less than 2%.</p><h3>Ocular</h3><p>Eye itch occurred in less than 2%.</p><p><b>Frequency not reported</b>: Eye itch</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety </p>
<p><b>Frequency not reported</b>: Insomnia</p><p>Insomnia occurred in less than 2%.</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Nelson HS, Bensch G, Pleskow WW, DiSantostefano R, DeGraw S, Reasner DS, Rollins TE, Rubin PD "Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma." J Allergy Clin Immunol 102 (1998): 943-52</p><p id="ref_2">2. "Product Information. Xopenex (levalbuterol)." Sepracor, Marlborough, MA. </p><p id="ref_3">3. Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS "The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients." J Allerg Clin Immunol 103 (1999): 615-21</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Xopenex HFA (levalbuterol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Drug class: adrenergic bronchodilators</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xopenex HFA &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Xopenex</li>
<li>Xopenex Concentrate</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>COPD</li>
<li>COPD, Maintenance</li>
<li>Asthma</li>
<li>Asthma, Maintenance</li>
<li>Asthma, acute</li>
<li>COPD, Acute</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to levalbuterol: inhalation aerosol, inhalation solution</i></p><h3>General</h3><p>This drug has been associated with paradoxical bronchospasm, cardiovascular effects, immediate hypersensitivity reactions, and hypokalemia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>ECG abnormal, ECG change, hypotension, and syncope occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Hypertension, tachycardia</p><p><b>Frequency not reported</b>: ECG abnormal, ECG change, hypotension, syncope</p><p><b>Postmarketing reports</b>: Arrhythmias (including atrial fibrillation, supraventricular tachycardia, extrasystoles)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Myalgia occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Leg cramps</p><p><b>Frequency not reported</b>: Myalgia<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Metabolic acidosis occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Changes in plasma glucose and serum potassium; metabolic acidosis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Central nervous system stimulation and hyperesthesia of the hand occurred in less than 2%.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Dizziness, migraine, tremor, nervousness</p><p><b>Frequency not reported</b>: Central nervous system stimulation, hyperesthesia of the hand<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pain, flu syndrome, accidental injury, asthenia, fever</p><p><b>Frequency not reported</b>: Ear pain, herpes simplex, chills, cyst<sup>[Ref]</sup></p><p>Ear pain, herpes simplex, chills, and cyst occurred in less than 2%.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Diarrhea, dry mouth, dry throat, nausea, gastroenteritis, vomiting, and constipation occurred in less than 2%.</p><p><b>Common</b> (1% to 10%): Dyspepsia</p><p><b>Frequency not reported</b>: Diarrhea, dry mouth, dry throat, nausea, gastroenteritis, vomiting, constipation</p><p><b>Postmarketing reports</b>: Gastroesophageal reflux disease (GERD), nausea</p><h3>Respiratory</h3><p>Viral infection, epistaxis, lung disorder, asthma exacerbation, and wheezing occurred in less than 2%.</p><p><b>Common</b> (1% to 10%): Asthma, pharyngitis, rhinitis, bronchitis, sinusitis, turbinate edema, cough increased, viral infection</p><p><b>Frequency not reported</b>: Epistaxis, lung disorder, asthma exacerbation, wheezing</p><p><b>Postmarketing reports</b>: Chest pain, dysphonia, dyspnea</p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Acne, sweating</p><p><b>Postmarketing reports</b>: Rash, urticaria</p><p>Acne and sweating occurred less than 2%.</p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic reactions</p><p><b>Postmarketing reports</b>: Angioedema, anaphylaxis</p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hematuria, dysmenorrhea, vaginal moniliasis</p><p>Hematuria, dysmenorrhea, vaginal moniliasis occurred in less than 2%.</p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Lymphadenopathy</p><p>Lymphadenopathy occurred in less than 2%.</p><h3>Ocular</h3><p>Eye itch occurred in less than 2%.</p><p><b>Frequency not reported</b>: Eye itch</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety </p><p><b>Frequency not reported</b>: Insomnia</p><p>Insomnia occurred in less than 2%.</p><p id="ref_1">1. Nelson HS, Bensch G, Pleskow WW, DiSantostefano R, DeGraw S, Reasner DS, Rollins TE, Rubin PD "Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma." J Allergy Clin Immunol 102 (1998): 943-52</p><p id="ref_2">2. "Product Information. Xopenex (levalbuterol)." Sepracor, Marlborough, MA. </p><p id="ref_3">3. Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS "The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients." J Allerg Clin Immunol 103 (1999): 615-21</p><h2>More about Xopenex HFA (levalbuterol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Drug class: adrenergic bronchodilators</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xopenex HFA &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Xopenex</li>
<li>Xopenex Concentrate</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>COPD</li>
<li>COPD, Maintenance</li>
<li>Asthma</li>
<li>Asthma, Maintenance</li>
<li>Asthma, acute</li>
<li>COPD, Acute</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>